↓ Skip to main content

Molecular subgroups of medulloblastoma: the current consensus

Overview of attention for article published in Acta Neuropathologica, December 2011
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
1 news outlet
blogs
2 blogs
twitter
2 X users
patent
8 patents
wikipedia
9 Wikipedia pages
googleplus
2 Google+ users
f1000
1 research highlight platform

Citations

dimensions_citation
1551 Dimensions

Readers on

mendeley
1238 Mendeley
Title
Molecular subgroups of medulloblastoma: the current consensus
Published in
Acta Neuropathologica, December 2011
DOI 10.1007/s00401-011-0922-z
Pubmed ID
Authors

Michael D. Taylor, Paul A. Northcott, Andrey Korshunov, Marc Remke, Yoon-Jae Cho, Steven C. Clifford, Charles G. Eberhart, D. Williams Parsons, Stefan Rutkowski, Amar Gajjar, David W. Ellison, Peter Lichter, Richard J. Gilbertson, Scott L. Pomeroy, Marcel Kool, Stefan M. Pfister

Abstract

Medulloblastoma, a small blue cell malignancy of the cerebellum, is a major cause of morbidity and mortality in pediatric oncology. Current mechanisms for clinical prognostication and stratification include clinical factors (age, presence of metastases, and extent of resection) as well as histological subgrouping (classic, desmoplastic, and large cell/anaplastic histology). Transcriptional profiling studies of medulloblastoma cohorts from several research groups around the globe have suggested the existence of multiple distinct molecular subgroups that differ in their demographics, transcriptomes, somatic genetic events, and clinical outcomes. Variations in the number, composition, and nature of the subgroups between studies brought about a consensus conference in Boston in the fall of 2010. Discussants at the conference came to a consensus that the evidence supported the existence of four main subgroups of medulloblastoma (Wnt, Shh, Group 3, and Group 4). Participants outlined the demographic, transcriptional, genetic, and clinical differences between the four subgroups. While it is anticipated that the molecular classification of medulloblastoma will continue to evolve and diversify in the future as larger cohorts are studied at greater depth, herein we outline the current consensus nomenclature, and the differences between the medulloblastoma subgroups.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 1,238 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 10 <1%
United Kingdom 4 <1%
Germany 3 <1%
Japan 3 <1%
Netherlands 2 <1%
Canada 2 <1%
Brazil 1 <1%
Czechia 1 <1%
Italy 1 <1%
Other 4 <1%
Unknown 1207 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 182 15%
Student > Bachelor 154 12%
Researcher 149 12%
Student > Master 123 10%
Other 89 7%
Other 248 20%
Unknown 293 24%
Readers by discipline Count As %
Medicine and Dentistry 356 29%
Biochemistry, Genetics and Molecular Biology 200 16%
Agricultural and Biological Sciences 182 15%
Neuroscience 61 5%
Pharmacology, Toxicology and Pharmaceutical Science 15 1%
Other 100 8%
Unknown 324 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 37. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 August 2023.
All research outputs
#1,094,996
of 25,339,932 outputs
Outputs from Acta Neuropathologica
#170
of 2,541 outputs
Outputs of similar age
#6,495
of 252,181 outputs
Outputs of similar age from Acta Neuropathologica
#2
of 27 outputs
Altmetric has tracked 25,339,932 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,541 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 16.6. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 252,181 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 27 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.